161 related articles for article (PubMed ID: 19151767)
21. Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance.
To K; Fotovati A; Reipas KM; Law JH; Hu K; Wang J; Astanehe A; Davies AH; Lee L; Stratford AL; Raouf A; Johnson P; Berquin IM; Royer HD; Eaves CJ; Dunn SE
Cancer Res; 2010 Apr; 70(7):2840-51. PubMed ID: 20332234
[TBL] [Abstract][Full Text] [Related]
22. Met receptor signaling: a key effector in esophageal adenocarcinoma.
Anderson MR; Harrison R; Atherfold PA; Campbell MJ; Darnton SJ; Obszynska J; Jankowski JA
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5936-43. PubMed ID: 17062664
[TBL] [Abstract][Full Text] [Related]
23. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity.
Liang H; O'Reilly S; Liu Y; Abounader R; Laterra J; Maher VM; McCormick JJ
Int J Oncol; 2004 May; 24(5):1057-67. PubMed ID: 15067326
[TBL] [Abstract][Full Text] [Related]
24. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.
Berquin IM; Pang B; Dziubinski ML; Scott LM; Chen YQ; Nolan GP; Ethier SP
Oncogene; 2005 Apr; 24(19):3177-86. PubMed ID: 15735691
[TBL] [Abstract][Full Text] [Related]
25. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light.
Ohga T; Koike K; Ono M; Makino Y; Itagaki Y; Tanimoto M; Kuwano M; Kohno K
Cancer Res; 1996 Sep; 56(18):4224-8. PubMed ID: 8797596
[TBL] [Abstract][Full Text] [Related]
26. Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells.
Basaki Y; Taguchi K; Izumi H; Murakami Y; Kubo T; Hosoi F; Watari K; Nakano K; Kawaguchi H; Ohno S; Kohno K; Ono M; Kuwano M
Eur J Cancer; 2010 Mar; 46(5):954-65. PubMed ID: 20079629
[TBL] [Abstract][Full Text] [Related]
27. Regulation of c-met expression by transcription repressor Daxx.
Morozov VM; Massoll NA; Vladimirova OV; Maul GG; Ishov AM
Oncogene; 2008 Apr; 27(15):2177-86. PubMed ID: 17952115
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1 (HIF-1) in tumour cells in papillary carcinoma of the thyroid.
Scarpino S; Cancellario d'Alena F; Di Napoli A; Pasquini A; Marzullo A; Ruco LP
J Pathol; 2004 Mar; 202(3):352-8. PubMed ID: 14991901
[TBL] [Abstract][Full Text] [Related]
29. Ets up-regulates MET transcription.
Gambarotta G; Boccaccio C; Giordano S; AndÅ M; Stella MC; Comoglio PM
Oncogene; 1996 Nov; 13(9):1911-7. PubMed ID: 8934537
[TBL] [Abstract][Full Text] [Related]
30. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
Fujii T; Kawahara A; Basaki Y; Hattori S; Nakashima K; Nakano K; Shirouzu K; Kohno K; Yanagawa T; Yamana H; Nishio K; Ono M; Kuwano M; Kage M
Cancer Res; 2008 Mar; 68(5):1504-12. PubMed ID: 18316615
[TBL] [Abstract][Full Text] [Related]
31. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic activation of the human Pygopus2 promoter by E74-like factor-1.
Andrews PG; Kennedy MW; Popadiuk CM; Kao KR
Mol Cancer Res; 2008 Feb; 6(2):259-66. PubMed ID: 18314487
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.
Seol DW; Chen Q; Zarnegar R
Oncogene; 2000 Feb; 19(9):1132-7. PubMed ID: 10713700
[TBL] [Abstract][Full Text] [Related]
35. Mimp, a mitochondrial carrier homologue, inhibits Met-HGF/SF-induced scattering and tumorigenicity by altering Met-HGF/SF signaling pathways.
Leibowitz-Amit R; Tsarfaty G; Abargil Y; Yerushalmi GM; Horev J; Tsarfaty I
Cancer Res; 2006 Sep; 66(17):8687-97. PubMed ID: 16951184
[TBL] [Abstract][Full Text] [Related]
36. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs impair MET-mediated invasive growth.
Migliore C; Petrelli A; Ghiso E; Corso S; Capparuccia L; Eramo A; Comoglio PM; Giordano S
Cancer Res; 2008 Dec; 68(24):10128-36. PubMed ID: 19074879
[TBL] [Abstract][Full Text] [Related]
38. An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma.
Kongkham PN; Northcott PA; Ra YS; Nakahara Y; Mainprize TG; Croul SE; Smith CA; Taylor MD; Rutka JT
Cancer Res; 2008 Dec; 68(23):9945-53. PubMed ID: 19047176
[TBL] [Abstract][Full Text] [Related]
39. A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells.
Wojcik EJ; Sharifpoor S; Miller NA; Wright TG; Watering R; Tremblay EA; Swan K; Mueller CR; Elliott BE
Oncogene; 2006 May; 25(19):2773-84. PubMed ID: 16407846
[TBL] [Abstract][Full Text] [Related]
40. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells.
Basaki Y; Hosoi F; Oda Y; Fotovati A; Maruyama Y; Oie S; Ono M; Izumi H; Kohno K; Sakai K; Shimoyama T; Nishio K; Kuwano M
Oncogene; 2007 Apr; 26(19):2736-46. PubMed ID: 17072343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
